<DOC>
	<DOCNO>NCT00507936</DOCNO>
	<brief_summary>This study compare efficacy safety ABT-894 ( 1mg , 2mg 4mg capsule ) administer BID placebo treatment DNP . Another treatment arm Duloxetine 60mg administer daily ( QD ) . Approximately 275 subject enrol study approximately 50 site United States Europe . The study divide follow period : Screening/Washout ( 21 day ) follow Baseline Visit , 8-week Treatment Period 1-week Follow-up Visit .</brief_summary>
	<brief_title>Safety Efficacy Study Subjects With Diabetic Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>If female , subject either postmenopausal least two ( 2 ) year surgically sterile practice least one ( 1 ) method birth control . If female , subject must negative result pregnancy test . The subject must diagnosis diabetes mellitus ( Type 1 Type 2 ) diagnosis DNP . Subject 's DNP must present minimum six ( 6 ) month begin foot relative symmetrical onset . Subject HgbA1c &lt; = 9 . Subjects HgbA1c &gt; 9 &lt; = 11 may include study . If male , subject surgically sterile ( vasectomy ) , sexually inactive , use barrier method ( condom ) birth control duration study 7 day follow last dose study drug . The subject fail previous treatment duloxetine DNP . Subject diagnosis narrowangle glaucoma . Subject history allergic reaction intolerance duloxetine , acetaminophen , NNR agonist . Subject diagnosis fibromyalgia require treatment . Subject functioning implant medical device ( spinal cord stimulator , intrathecal pump peripheral nerve stimulator ) treatment neuropathic pain . Subject history seizure ( febrile may ok ) major depressive episode within past two ( 2 ) year major psychiatric disorder include bipolar disorder , schizophrenia borderline personality disorder . Subject history myocardial infarction ( MI ) within six ( 6 ) month Screening Visit . Subject unstable angina . Subject ventricular arrhythmia require antiarrhythmic therapy . Subject undergone cardiac revascularization procedure within 30 day Screening . Subject uncontrolled hypertension ( HTN ) define systolic blood pressure ( BP ) &gt; = 160 and/or diastolic blood pressure ( BP ) &gt; = 100 Screening and/or Baseline . Subject clinically significant abnormal ECG Screening Subject active malignancy type diagnose treated cancer within past 5 year . Subject positive result drug abuse Screening exception positive result know prescribed medication . Subject 's screen laboratory result show hepatitis A , B C. Subject know suspect history Human Immunodeficiency Virus ( HIV ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Diabetic Neuropathy</keyword>
	<keyword>Painful</keyword>
	<keyword>Diabetic Polyneuropathy</keyword>
	<keyword>Neuralgia</keyword>
	<keyword>Diabetic</keyword>
	<keyword>Diabetic Neuropathies</keyword>
	<keyword>Diabetic Neuralgia</keyword>
</DOC>